Video 3




As pharma companies have a mandate to reduce costs and  look  to optimise their supply chains globally and ensure that patients receive drugs on time, Arriete Van Strien, Senior VP, Commercial Operations at Marken,  spoke to Pharma IQ at the recent Clincial Trial Supply Conference in Basel on what  the new GDP guidleines for regulations will mean to the Pharma industry and explains the role of Marken on becoming an extended CRO to their customers as they approach regulatory changes.